Global Veterinary Regenerative Medicine Market Size study & Forecast, by Animal Type (Small Animals, Large Animals) by Product( Stem Cells, Others), by Application (Orthopedics, Trauma/Wound Care and Others), by End Use ( Veterinary Hospitals/Clinics, Vet

Global Veterinary Regenerative Medicine Market Size study & Forecast, by Animal Type (Small Animals, Large Animals) by Product( Stem Cells, Others), by Application (Orthopedics, Trauma/Wound Care and Others), by End Use ( Veterinary Hospitals/Clinics, Veterinary Research Institutes) and Regional Analysis, 2022-2029

Global Veterinary Regenerative Medicine Market is valued at approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. New cell and tissue therapies for animals are actively being researched in the field of veterinary regenerative medicine. Animal cells, tissues, and cell- and tissue-based products, or ACTPs for short, are the substances used in these treatments. Animal-safe products that contain, include, or arise from cells or tissues are referred to by this phrase. The Veterinary Regenerative Medicine market is expanding because of increasing pet expenditure and growing Research and development in veterinary regenerative medicine. However, high Cost of Veterinary Regenerative Medicine may halt market growth.

Rising adoption of pet across the world is favouring the market growth. For instance: according to a 2021 survey by the American Pet Products Association, there are 69 million dog-owning households in the United States. Adopting pets has therefore recently gained popularity among families, especially nuclear families. Approximately 90.5 million households in the United States, or 70%, have pets, according to the APPA Survey 2021–2022. Along with these rise in research and development activities, prevalence of acute & chronic diseases in pets and rising initiatives by the key players for product development activities in the region is creating a lucrative growth to the market.

The key regions considered for the Global Veterinary Regenerative Medicine Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the rising pet adoption, rising research, and product development activities by key market players. Whereas Asia Pacific is expected to grow with a highest CAGR during the forecast period, owing to factors such as rising target populations, an increase in the number of collaborations for medicine development, geographic expansion of key players, and active participation of government and nonprofit organizations in the market space.

Major market player included in this report are:
Boehringer Ingelheim International Gmbh
Zoetis
Dechra
Acell Inc. (Integra Lifesciences)
Vetherapy
Vetstem, Inc.
Ardent
Enso Discoveries
Animal Cell Therapies, Inc.
Vetbiologics

Recent Developments in the Market:
In September 2021, Dechra acquired marketing and distribution rights of ProVet BMC and ProVet APC systems from Hassinger Biomedical. These patented medical devices helped the company expand its equine product line and boosted its market position in the veterinary regenerative medicine market.

Global Veterinary Regenerative Medicine Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Animal Type, Product, Application, End Use, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Animal Type offerings of key players.

The detailed segments and sub-segment of the market are explained below:

By Animal Type:
Small Animals
Large Animals
By Product:
Stem Cells
Others
By Application:
Orthopedics
Trauma/Wound Care
Others
By End Use:
Veterinary Hospitals/Clinics
Veterinary Research Institutes
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World

Companies Mentioned

Boehringer Ingelheim International Gmbh
Zoetis
Dechra
Acell Inc. (Integra Lifesciences)
Vetherapy
Vetstem, Inc.
Ardent
Enso Discoveries
Animal Cell Therapies, Inc.
Vetbiologics

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.